Lizares, Daisy B.

HRN: 26-78-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2025
CEFTRIAXONE 1G (VIAL)
03/09/2025
03/16/2025
IV
2g
OD
UTI
Waiting Final Action 
03/09/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/09/2025
03/16/2025
IV
500mg
Q8hrs
Intestinal Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: